July 20, 2023 Philip Morris To Acquire Israeli Cannabis Inhaler Company Syqe Medical For Up To $650 Million View Article
July 19, 2023 FDA clearance opens up MeMed’s bacteria-versus-virus blood test to the point-of-care View Article
July 18, 2023 Philip Morris acquiring Cannabis inhaler developer Syqe Medical for up to $650 million View Article
July 17, 2023 Motive Infrastructure Solutions and Galooli Partner for Enhanced Intelligence in Remote Energy Services View Article
July 12, 2023 Galooli and Oztron Partner to Provide End-to-End Energy Efficiency Solutions to Australian Market View Article
June 29, 2023 PolyPid Announces New Publication Highlighting Potent Antibacterial Activity of D-PLEX₁₀₀ against Susceptible and Resistant Bacteria for the Prevention of Surgical Site Infections View Article
June 22, 2023 PolyPid Announces Recruitment of First Patient in Revised SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for Prevention of Abdominal Colorectal Surgical Site Infections View Article
June 21, 2023 Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 View Article
June 12, 2023 Lightricks: How AI-powered image creation (and editing) will impact the creator economy View Article
